Armata Pharmaceuticals, Inc. Common Stock ARMP

$4.68 +2.63% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-12 View →
8-K 8-K 2026-08-12 View →
8-K FORM 8-K 2026-07-20 View →
8-K FORM 8-K 2026-07-20 View →
4 OWNERSHIP DOCUMENT 2026-07-14 View →
8-K FORM 8-K 2026-07-13 View →
8-K FORM 8-K 2026-06-23 View →
8-K FORM 8-K 2026-06-16 View →
10-Q 10-Q 2026-05-13 View →
8-K 8-K 2026-05-13 View →
8-K FORM 8-K 2026-05-07 View →
4 OWNERSHIP DOCUMENT 2026-04-28 View →
DEF 14A DEF 14A 2026-04-27 View →
8-K FORM 8-K 2026-04-27 View →
8-K FORM 8-K 2026-04-02 View →
10-K 10-K 2026-03-25 View →
8-K 8-K 2026-03-25 View →
8-K FORM 8-K 2026-03-19 View →
4 OWNERSHIP DOCUMENT 2026-03-17 View →
4 OWNERSHIP DOCUMENT 2026-03-17 View →
4 OWNERSHIP DOCUMENT 2026-03-11 View →
4 OWNERSHIP DOCUMENT 2026-03-11 View →
4 OWNERSHIP DOCUMENT 2026-03-11 View →
4 OWNERSHIP DOCUMENT 2026-03-11 View →
4 OWNERSHIP DOCUMENT 2026-03-11 View →
4 OWNERSHIP DOCUMENT 2026-03-11 View →
4 OWNERSHIP DOCUMENT 2026-03-11 View →
4 OWNERSHIP DOCUMENT 2026-03-11 View →
4 OWNERSHIP DOCUMENT 2026-03-11 View →
8-K FORM 8-K 2026-02-23 View →
8-K FORM 8-K 2026-01-26 View →
8-K FORM 8-K 2026-01-13 View →
8-K FORM 8-K 2025-12-01 View →
424B5 424B5 2025-12-01 View →
10-Q 10-Q 2025-11-12 View →
8-K 8-K 2025-11-12 View →
8-K FORM 8-K 2025-10-22 View →
8-K FORM 8-K 2025-09-11 View →
S-3 FORM S-3 2025-08-13 View →
10-Q 10-Q 2025-08-12 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$4.68
Market Cap
$166.58 million
52-Week Range
$2.24 – $16.34
Average Volume
147K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.